Clinical Trial Update: Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether methylprednisolone affects complement activation in patients undergoing total knee arthroplasty. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Osteoarthrosis | Phase 3 | Status: COMPLETED